Farther Finance Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Buy |
5,349
+5,264
| +6,193% | +$28K | ﹤0.01% | 2447 |
|
|
2025
Q1 | $751 | Sell |
85
-27
| -24% | -$239 | ﹤0.01% | 3695 |
|
|
2024
Q4 | $1.54K | Sell |
112
-89
| -44% | -$1.22K | ﹤0.01% | 3107 |
|
|
2024
Q3 | $5.5K | Buy |
201
+9
| +5% | +$246 | ﹤0.01% | 2595 |
|
|
2024
Q2 | $4.6K | Sell |
192
-68
| -26% | -$1.63K | ﹤0.01% | 2431 |
|
|
2024
Q1 | $5.57K | Buy |
260
+226
| +665% | +$4.85K | ﹤0.01% | 2019 |
|
|
2023
Q4 | $651 | Buy |
34
+19
| +127% | +$364 | ﹤0.01% | 2883 |
|
|
2023
Q3 | $241 | Sell |
15
-199
| -93% | -$3.2K | ﹤0.01% | 2435 |
|
|
2023
Q2 | $4.96K | Hold |
214
| – | – | ﹤0.01% | 1437 |
|
|
2023
Q1 | $4.97K | Buy |
214
+199
| +1,327% | +$4.62K | ﹤0.01% | 1342 |
|
|
2022
Q4 | $218 | Buy |
+15
| New | +$218 | ﹤0.01% | 2027 |
|